138 related articles for article (PubMed ID: 7037894)
1. An amelanotic melanoma transformed into melanotic melanoma with development of vitiligo.
Takematsu H; Tomita Y; Sato A; Seiji M
J Dermatol; 1981 Dec; 8(6):431-8. PubMed ID: 7037894
[No Abstract] [Full Text] [Related]
2. Do we have to pay more attention to vitiligo patients? Peculiar histopathological features of primary cutaneous melanoma preceded by vitiligo.
Onsun N; Büyükbabani N; Ummetoğlu O; Cebeci F
J Dermatol; 2009 Nov; 36(11):612-5. PubMed ID: 19878396
[TBL] [Abstract][Full Text] [Related]
3. Malignant melanoma and vitiligo.
Balabanov K; Andreev VC; Tchernozemski I
Dermatologica; 1969; 139(3):211-9. PubMed ID: 5808472
[No Abstract] [Full Text] [Related]
4. Direct evidence to support the role of antigen-specific CD8(+) T cells in melanoma-associated vitiligo.
Le Gal FA; Avril MF; Bosq J; Lefebvre P; Deschemin JC; Andrieu M; Dore MX; Guillet JG
J Invest Dermatol; 2001 Dec; 117(6):1464-70. PubMed ID: 11886510
[TBL] [Abstract][Full Text] [Related]
5. Melanocyte-specific, cytotoxic T cell responses in vitiligo: the effective variant of melanoma immunity?
Garbelli S; Mantovani S; Palermo B; Giachino C
Pigment Cell Res; 2005 Aug; 18(4):234-42. PubMed ID: 16029417
[TBL] [Abstract][Full Text] [Related]
6. Regressing cutaneous malignant melanoma and vitiligo-like depigmentation.
Arpaia N; Cassano N; Vena GA
Int J Dermatol; 2006 Aug; 45(8):952-6. PubMed ID: 16911383
[No Abstract] [Full Text] [Related]
7. [Malignant melanoma, leukoderma and vitiligo].
Kraus L; Landthaler M
Z Hautkr; 1980 Feb; 55(4):218-31. PubMed ID: 6996365
[TBL] [Abstract][Full Text] [Related]
8. Vitiligo associated with metastatic malignant melanoma.
Cavallari V; Cannavò SP; Ussia AF; Moretti G; Albanese A
Int J Dermatol; 1996 Oct; 35(10):738-40. PubMed ID: 8891830
[No Abstract] [Full Text] [Related]
9. New perspectives on the role of vitiligo in immune responses to melanoma.
Byrne KT; Turk MJ
Oncotarget; 2011 Sep; 2(9):684-94. PubMed ID: 21911918
[TBL] [Abstract][Full Text] [Related]
10. Melanoma, vitiligo and topographic antigens.
James DB
Melanoma Res; 1993 Feb; 3(1):76-7. PubMed ID: 8471841
[No Abstract] [Full Text] [Related]
11. [Spontaneous regression and leukoderma in malignant melanoma].
Happle R; Schotola I; Macher E
Hautarzt; 1975 Mar; 26(3):120-3. PubMed ID: 1126845
[TBL] [Abstract][Full Text] [Related]
12. Regressing metastatic melanoma and vitiligo-like depigmentation in an Indigenous Australian.
Christou EM; Damian DL; Thompson JF
Med J Aust; 2010 Feb; 192(3):171. PubMed ID: 20121689
[No Abstract] [Full Text] [Related]
13. [Vitiliginous depigmentation in patients suffering from malignant melanoma].
Frenk E
Dermatologica; 1969; 139(1):84-91. PubMed ID: 5810156
[No Abstract] [Full Text] [Related]
14. Depigmentation: its significance in patients with melanoma.
Barnes L; Nordlund JJ
Clin Dermatol; 1989; 7(2):66-73. PubMed ID: 2667742
[No Abstract] [Full Text] [Related]
15. Iritis in patients with cutaneous melanoma and vitiligo.
Albert DM; Sober AJ; Fitzpatrick TB
Arch Ophthalmol; 1978 Nov; 96(11):2081-4. PubMed ID: 718499
[TBL] [Abstract][Full Text] [Related]
16. Sinclair miniature swine: an animal model of human melanoma.
Misfeldt ML; Grimm DR
Vet Immunol Immunopathol; 1994 Oct; 43(1-3):167-75. PubMed ID: 7856049
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the antigenicity of melanotic and amelanotic melanoma cells after the release of surface glycoproteins by trypsin.
Kozłowska K; Zurawska-Czupa B; Kostulak A
Arch Immunol Ther Exp (Warsz); 1980; 28(4):641-4. PubMed ID: 7192976
[TBL] [Abstract][Full Text] [Related]
18. Complete remission of metastatic malignant melanoma after surgery in association with development of systemic vitiligo.
Nishitani N; Bito T; Ikeda T; Tokura Y; Nishigori C
J Dermatol; 2010 Aug; 37(8):770-2. PubMed ID: 20649729
[No Abstract] [Full Text] [Related]
19. Comparison of cell-mediated immunity to melanoma cells in patients with vitiligo, halo nevi or melanoma.
Mitchell MS; Nordlund JJ; Lerner AB
J Invest Dermatol; 1980 Aug; 75(2):144-7. PubMed ID: 7410884
[No Abstract] [Full Text] [Related]
20. Hypopigmented malignant melanoma simulating vitiligo.
Kossard S; Commens C
J Am Acad Dermatol; 1990 May; 22(5 Pt 1):840-2. PubMed ID: 2347968
[No Abstract] [Full Text] [Related]
[Next] [New Search]
